Role and responsibilities within the QRC-PVD:

Currently, I lead one of the preclinical team within the QRC-PVD with a special focus on development and use of preclinical models of blocked arteries (peripheral arterial diseases; PAD) and weakened arteries (abdominal aortic aneurysms; AAA). Translational research involves applying insights and discoveries generated by basic scientific inquiry for the treatment or prevention of human diseases. The long-term objective of the translational research program in the QRC-PVD is to develop new treatments for PAD and AAA. One of the limitations of preclinical work is the lack of appropriate pre-clinical models covering important aspects of the human disease. To address this problem, one focus of the research within the QRC-PVD has been examining the clinical relevance of pre-clinical models. The models currently being assessed within the QRC-PVD include various models of AAA, lower limb ischemia and stroke.

I am also involved in the QRC-PVD Management and Biobank Sample committees to facilitate goal oriented progress of the team. I currently co-supervise 4 PhD students that are working on the topics of therapeutic revascularisation in lower limb ischemia and nutritional intervention in AAA. I invite expressions of interest from capable and committed prospective students interested in becoming involved in peripheral artery research.

I was awarded a PhD in 2006 in Cancer Biology from the Laboratory of Tumour Immunology and Functional Genomics in Regional Cancer Centre, India. The project focused on the viral and environmental interaction of various cell-cycle regulatory proteins which lead to cancer. The work identified crucial molecular pathways which are affected by the DNA virus infection and the relation to the response of the patients to anti-cancer therapy. I did my Postdoctoral research in the Immunology Department in the Faculty of Medicine & Health Sciences in UAE University and worked for 3 years in the Molecular Biology & Genetics Laboratory under the Dubai Government as a Senior Research Scientist. My work mainly focused on analysis of gene expression patterns and epigenetic silencing of genes under physiological and environmental stress. The research involved sophisticated molecular biology techniques including development of cDNA libraries, BAC libraries, SNP analysis and microarray analysis. I joined the QRC-PVD in 2009 and continued researching on the genetic and epigenetic alterations leading to the development of PAD.


My primary interest is translational research aimed at better understanding the molecular and cellular mechanisms involved in development and progression of PAD and AAA.

Specific interests include:

1. Developing and refining Preclinical models of PAD and AAA.

2. Testing therapeutic interventions in preclinical models;

3. Genetic and epigenetic alterations in the pathology of PAD and AAA. 

  • Atherosclerosis, cardiovascular, Vascular, ischemia, angiogenesis, epigenetics, funtional genomics, nutrigenomics
Research Disciplines
Socio-Economic Objectives

These are the most recent publications associated with this author. To see a detailed profile of all publications stored at JCU, visit ResearchOnline@JCU. Hover over Altmetrics badges to see social impact.

Journal Articles

ResearchOnline@JCU stores 55+ research outputs authored by Dr Smriti Murali Krishna from 2004 onwards.

Current Funding

Current and recent Research Funding to JCU is shown by funding source and project.

Diabetes Australia - General Grant

Testing a novel treatment for diabetes-associated ischemic foot ulceration.

Indicative Funding
$60,000 over 1 year
5000 Australians with diabetes have a leg amputations each year. This project investigates a novel drug therapy approach to reducing the need for leg amputations within an established rodent model. The aim of the study is to assess if administration of a direct activator of adenosine-5'-monophosphate (AMP)-activated protein kinase (AMPK) will promote healing within a rat model of diabetes and limb ischaemia-associated foot ulceration.
Jon Golledge, Smriti Krishna and Joseph Moxon in collaboration with Jon Oakhill, Michelle Keske and Valerie Schini-Kerth (College of Medicine & Dentistry, St Vincent's Institute of Medical Research, Deakin University and University of Strasbourg)
peripheral artery disease; Diabetes; rodent model

Advisory Accreditation: I can be on your Advisory Panel as a Primary or Secondary Advisor.

These Higher Degree Research projects are either current or by students who have completed their studies within the past 5 years at JCU. Linked titles show theses available within ResearchOnline@JCU.

  • Development and Implementation of Plasma Polymer Thin Films for Enhanced Biocompatibility in Medical Implants (PhD , Secondary Advisor)
  • Assessment and Intervention of Dietary Patterns in Patients with Peripheral Arterial Disease and Abdominal Aortic Aneurysm (PhD , Secondary Advisor)

The map shows research collaborations by institution from the past 7 years.
Note: Map points are indicative of the countries or states that institutions are associated with.

  • 5+ collaborations
  • 4 collaborations
  • 3 collaborations
  • 2 collaborations
  • 1 collaboration
  • Indicates the Tropics (Torrid Zone)

Connect with me
Share my profile
Share my profile:

Advisory Accreditation
Primary Advisor
Find me on…
Icon for ResearcherID page Icon for Scopus Author page Icon for ORCID profile Icon for LinkedIn profile page Icon for Publons reviewer profile Icon for Twitter profile page Icon for Google Scholar profile Icon for ResearchGate profile

Similar to me

  1. Dr Joseph Moxon
  2. Dr Tejas Singh